Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH
21 search results for:

Teriparatide 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 18-02-2022 | Osteoporosis | News | Article
    approvalsWatch

    EMA recommends approval of teriparatide biosimilar for osteoporosis

    medwireNews : The EMA’s Committee for Medicinal Products for Human Use adopted a positive opinion recommending approval of a teriparatide biosimilar for the treatment of osteoporosis.

    Author:
    Claire Barnard
  2. 09-09-2019 | Osteoporosis | News | Article

    Denosumab plus high-dose teriparatide may improve postmenopausal osteoporosis

    Combining denosumab with high-dose rather than standard-dose teriparatide results in greater increases in spine and hip bone mineral density in postmenopausal women with osteoporosis, phase IV study data show.

    Published in:
    Lancet Diabetes Endocrinol 2019; doi:10.1016/S2213-8587(19)30255-4 Lancet Diabetes Endocrinol 2019; doi: 10.1016/S2213-8587(19)30266-9
  3. 07-06-2017 | Rheumatoid arthritis | News | Article

    Teriparatide disappoints in RA trial

    Treatment with teriparatide, a recombinant form of parathyroid hormone, does not reduce joint erosion among patients with rheumatoid arthritis undergoing treatment with tumor necrosis factor inhibitors, researchers report.

    Published in:
    Arthritis Rheumatol 2017; Advance online publication
  4. 23-02-2018 | Osteoporosis | Case report | Article

    Multiple vertebral fractures associated with glucocorticoid-induced osteoporosis treated with teriparatide followed by kyphosis correction fusion: A case report

    The authors report the case of a 24-year-old woman diagnosed with glucocorticoid-induced osteoporosis in which initial treatment with teriparatide followed by treatment of kyphosis with correction fusion achieved a favorable outcome. Uei H et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4425-9

  5. 23-02-2018 | Osteoporosis | Highlight | Teaser
    Journal article

    Multiple vertebral fractures associated with glucocorticoid-induced osteoporosis treated with teriparatide followed by kyphosis correction fusion: A case report

    The authors report the case of a 24-year-old woman diagnosed with glucocorticoid-induced osteoporosis in which initial treatment with teriparatide followed by treatment of kyphosis with correction fusion achieved a favorable outcome [ read more ]. Uei H et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4425-9

  6. 22-02-2016 | Osteoporosis | Review | Article

    Teriparatide for osteoporosis: importance of the full course

    Lindsay et al. conclude that osteoporosis patients at high risk for fracture being treated with teriparatide should follow the full 24-month treatment course in order to achieve the best clinical outcomes. Lindsay R et al. Osteoporos Int 2016;27:2395–2410. doi:10.1007/s00198-016-3534-6

  7. 31-07-2018 | Osteoporosis | News | Article

    'Dismal' rates of osteoporosis treatment initiation after hip fracture

    Of 97,169 patients aged an average of 80.2 years who were not taking osteoporosis medication at the time of hip fracture, only 6.9% initiated treatment with bisphosphonates, teriparatide, or denosumab within 180 days of their fracture.

    Published in:
    JAMA Network Open 2018; 1 : e180826, e180844
  8. 30-07-2018 | Osteoporosis | Review | Article

    Glucocorticoid-induced osteoporosis: Update on management

    Jagpal A, Saag KG. Curr Treat Options in Rheum 2018. doi: 10.1007/s40674-018-0105-3

  9. 30-06-2017 | Osteoporosis | Review | Article

    Using osteoporosis therapies in combination

    This review summarizes the evidence on using of osteoporosis drugs in combination and, with the exception of adding teriparatide to denosumab, finds little data to support using more than one drug at a time. McClung MR. Curr Osteoporos Rep 2017;15:343–352. doi:10.1007/s11914-017-0376-x

  10. 05-08-2017 | Osteoporosis | Review | Article

    New anabolic therapies for osteoporosis

    The authors provide an overview of the new drugs on the horizon, abaloparatide and romosozumab, which stimulate bone formation, and therefore improve bone mass, structure, and ultimately skeletal strength.2 Minisola S, Cipriani C, Occhiuto M, Pepe J. Intern Emerg Med 2017. doi:10.1007/s11739-017-1719-4

  11. 04-06-2018 | Osteoporosis | Review | Article

    Review of the guideline of the American College of Physicians on the treatment of osteoporosis

    Kanis, JA et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4504-y

  12. 08-05-2018 | Osteoarthritis | Article

    Benefits and safety of dietary protein for bone health: An expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

    This summary of systematic reviews and meta-analyses addresses the benefits and risks of dietary protein intakes for bone health in adults. Rizzoli R et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4534-5

  13. 08-05-2018 | Osteoarthritis | Highlight | Teaser
    Journal article

    Benefits and safety of dietary protein for bone health—an expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

    This summary of systematic reviews and meta-analyses addresses the benefits and risks of dietary protein intakes for bone health in adults [ read more ]. Rizzoli R et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4534-5

  14. 12-04-2018 | Osteoporosis | Article

    Testosterone and Male Osteoporosis

    Shin DE et al. Clinic Rev Bone Miner Metab 2018; Advance online publication. doi: 10.1007/s12018-018-9245-0

  15. 16-03-2017 | Osteoporosis | Review | Article

    Parathyroid hormone and parathyroid hormone-related protein analogs in osteoporosis therapy

    This article reviews the efficacy and optimal use of parathyroid hormone and parathyroid hormone-related protein analogs in osteoporosis treatment. Leder BZ. Curr Osteoporos Rep 2017;15:110–119. doi:10.1007/s11914-017-0353-4

  16. 12-07-2016 | Osteoporosis | Book Chapter | Article

    Medical treatment of age related osteoporosis

    An expert summary of available therapies and those on the horizon for patients with osteoporosis including vitamin D, bisphosphonates, selective estrogen receptor modulators, denosumab, and teriparatide. Wong EK-C, Kim LH-Y, Papaioannou A. In: Osteoporosis in Older Persons . Edited by Duque G, Kile DP. Springer International Publishing Switzerland, 2016. doi:10.1007/978-3-319-25976-5_12

  17. 19-04-2017 | Osteoporosis | Review | Article

    UK clinical guideline for the prevention and treatment of osteoporosis

    This guideline, accredited by the National Institute of Health and Care Excellence, provides an overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management. Compston J, Cooper A, Cooper C et al. Arch Osteoporos 2017;12:43. doi:10.1007/s11657-017-0324-5

  18. 07-04-2017 | Osteoporosis | Review | Article

    Osteoporosis: A discussion on the past 5 years

    This review covers the recent advances in osteoporosis, including: Patient education, atypical femur fractures, vitamin supplementation, medication advances, post-fracture management, and screening/diagnostic modalities. Schweser KM, Crist BD. Curr Rev Musculoskelet Med 2017;10:265–274. doi:10.1007/s12178-017-9410-y

  19. 17-03-2017 | Osteoporosis | Review | Article

    Transient osteoporosis of the hip: Review of the literature

    The authors provide an overview of transient osteoporosis of the hip, covering the epidemiology, pathophysiology, etiology, diagnosis, treatment, and potential complications of the condition.1 Asadipooya K, Graves L, Greene LW. Osteoporos Int 2017;28:1805–1816. doi:10.1007/s00198-017-3952-0

  20. 18-01-2016 | Osteoporosis | Article

    Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis

    The authors assessed the efficacy of approved osteoporosis pharmacotherapies in preventing fracture and determined that teriparatide, risedronate, and etidronate led to a decreased vertebral fracture risk. Amiche MA et al. Osteoporos Int 2016;27:1989–1998. doi:10.1007/s00198-015-3476-4

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.